SOLA BIO
Sola Bio develops a modular bioreactor called Sola that empowers people to grow cells.
SOLA BIO
Industry:
Alternative Medicine Biotechnology Food And Beverage
Founded:
2013-03-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud OpenResty Google Adsense Google Cloud Global Multi-Region AdBlock Acceptable Ads Google Adsense For Domains
Founder
More informations about "Sola Bio"
Sola – Unfolding Cures for Patients
The SOLA team has been working diligently on creating effective gene-therapies for patients with neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and Huntington's …See details»
About – Sola - sola-bio.com
SOLA Biosciences (Boston, MA) is a pre-clinical-stage biopharmaceutical company with a 10-years R&D history, focusing on developing transformative gene-therapies to treat conformational diseases such as Amyotrophic Lateral …See details»
Science – Sola - sola-bio.com
SOLA has developed an innovative “JUMP70” technology, to activate the patients’ own protein folding system specifically to “Disease-causing Protein”. We have demonstrated that JUMP70 …See details»
SOLA Biosciences - Crunchbase Company Profile & Funding
SOLA Biosciences is located in Tel Aviv, Tel Aviv, Israel. Who invested in SOLA Biosciences? SOLA Biosciences has 2 investors including Eisai Innovation and MP Healthcare Venture …See details»
SOLA Biosciences LLC - Drug pipelines, Patents, Clinical trials
Explore SOLA Biosciences LLC with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Infectious Diseases, Nervous System Diseases, Technology …See details»
Sola Biosciences - PitchBook
Sola Biosciences General Information Description. Developer of transformative gene therapies designed to treat conformational diseases. The company uses its proprietary chaperone platform technology to develop therapeutics for …See details»
Sola Biosciences, Inc. - UTEC-The University of Tokyo Edge Capital ...
SOLA owns the JUMP70 platform, a gene therapy that uses AAV to express JUMP70, a fusion protein capable of bringing disease-causing proteins into close proximity with the HSP70 …See details»
SOL-257 - Drug Targets, Indications, Patents - Synapse - Patsnap
BOSTON--(BUSINESS WIRE)-- As a pioneer in innovative chaperone technology, SOLA Biosciences Inc. will present its compelling preclinical proof-of-concept data for SOL-257, a …See details»
Sola Biosciences, LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Sola Biosciences, LLC of Natick, MA. Get the latest business insights from Dun & Bradstreet.See details»
SOLA Biosciences - VentureRadar
SOLA Biosciences dedicates to develop gene-therapies for patients with neurodegenerative diseases by Engineered Targeting Chaperone Platform Technology (JUMP70) designed to …See details»
SOLA Biosciences - Funding, Financials, Valuation & Investors
Sep 9, 2021 SOLA Biosciences has raised 1 round. This was a Seed round raised on Sep 9, 2021. SOLA Biosciences is funded by 2 investors. Eisai Innovation and MP Healthcare …See details»
Pipeline – Sola - sola-bio.com
Our designed JUMP70 technology targeting TDP-43 (SOL-257) enables specific elimination of “bad TDP-43”, and significantly improves protein folding issues associated with TDP-43 in …See details»
SOLA Biosciences - Updates, News, Events, Signals & Triggers
The company is also mentioned in relation to Huntington's disease, suggesting a diversification of its research and development efforts into different therapeutic areas. Furthermore, SOLA …See details»
SOLA Biosciences - Company Profile - Tracxn
SOLA Biosciences - Proprietary technology to increase production of proteins. Raised funding from 2 investors. Founded by Akinori Hishiya in the year 2016. SOLA Biosciences has 2769 …See details»
Biobased Economy Members – BIO
BIO is the champion of the global biobased economy – the value chain of sustainable and transformative biology-driven innovations BIO is the only global organization that brings …See details»
News – Sola - sola-bio.com
SOLA Biosciences Presents Preclinical Proof-of-Concept Data for SOL-257, a Gene Therapy Targeting Misfolded TDP-43 in ALS, at Neuroscience 2023 and ALS One Symposium. Read …See details»
SOLA Biosciences - Contacts, Employees, Board Members
SOLA Biosciences has 1 current employee profile, CEO and President, Founder Keizo Koya. Keizo Koya CEO and President, Founder Unlock even more features with Crunchbase ProSee details»
Synbio Hyperintegration
We use proprietary SynBio Hyperintegration Algorithms (SHAs), which deliver customized, for each SynBio product, modular plant architectures, called BioNodes, with unique performance …See details»
Benefits of Sunlight: A Bright Spot for Human Health - PMC
However, excessive UVR exposure accounts for only 0.1% of the total global burden of disease in disability-adjusted life years (DALYs), according to the 2006 World Health Organization …See details»
Zionism in Canada – Dictionary of Canadian Biography
Nov 8, 2023 De Sola thought that obtaining a legally secured home for the Jewish people in Palestine despite the presence of an Indigenous population, would enhance the physical and …See details»